9999999995-18-001761.txt : 20180712 9999999995-18-001761.hdr.sgml : 20180712 20180712001529 ACCESSION NUMBER: 9999999995-18-001761 CONFORMED SUBMISSION TYPE: EFFECT PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20180711 DATE AS OF CHANGE: 20180712 EFFECTIVENESS DATE: 20180711 FILER: COMPANY DATA: COMPANY CONFORMED NAME: SELLAS Life Sciences Group, Inc. CENTRAL INDEX KEY: 0001390478 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: EFFECT SEC ACT: 1933 Act SEC FILE NUMBER: 333-225140 FILM NUMBER: 18949571 BUSINESS ADDRESS: STREET 1: 315 MADISON AVENUE STREET 2: 4TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10017 BUSINESS PHONE: (813) 864-4523 MAIL ADDRESS: STREET 1: 315 MADISON AVENUE STREET 2: 4TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10017 FORMER COMPANY: FORMER CONFORMED NAME: Galena Biopharma, Inc. DATE OF NAME CHANGE: 20110926 FORMER COMPANY: FORMER CONFORMED NAME: RXi Pharmaceuticals Corp DATE OF NAME CHANGE: 20110926 FORMER COMPANY: FORMER CONFORMED NAME: GALENA BIOPHARMA, INC. DATE OF NAME CHANGE: 20110922 EFFECT 1 primary_doc.xml X0101 EFFECT 33 LIVE 2018-07-11 16:30:00

S-1

0001390478 SELLAS Life Sciences Group, Inc. 333-225140